The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, Y.
Right arrow Articles by Nakayama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, Y.
Right arrow Articles by Nakayama, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Eosinophilic Disorders
The Journal of Immunology, 2002, 169: 2134-2140.
Copyright © 2002 by The American Association of Immunologists

Ras Activation in T Cells Determines the Development of Antigen-Induced Airway Hyperresponsiveness and Eosinophilic Inflammation1

Youichi Shibata*,{ddagger}, Tohru Kamata*, Motoko Kimura*, Masakatsu Yamashita*,§, Chrong-Reen Wang{dagger},**, Kaoru Murata*, Masaru Miyazaki{ddagger}, Masaru Taniguchi*,||, Naohiro Watanabe# and Toshinori Nakayama2,*,{dagger}

Departments of * Molecular Immunology, {dagger} Medical Immunology, and {ddagger} General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan; § PRESTO, Tokyo, Japan; CREST Japan Science and Technology Corp., Tokyo, Japan; || Laboratory for Immune Regulation, RIKEN Research Center for Allergy and Immunology, Tokyo, Japan; # Department of Tropical Medicine, Jikei University School of Medicine, Tokyo, Japan; and ** Section of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Medical College, National Cheng Kung University, Tainan, Taiwan


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The central role for Th2 cells in the development of Ag-induced airway hyperresponsiveness and eosinophilic inflammation is well documented. We have reported a crucial role for TCR-induced activation of the Ras/extracellular signal-regulated kinase mitogen-activated protein kinase cascade in Th2 cell differentiation. Here, we show that the development of both OVA-induced airway hyperresponsiveness and eosinophilic airway inflammation in a mouse asthma model are attenuated in transgenic mice by the overexpression of enzymatically inactive Ras molecules in T cells. In addition, reduced levels of IL-5 production and eosinophilic inflammation induced by nematode infection (Nippostrongylus brasiliensis or Heligmosomoides polygyrus) were detected. Thus, the level of Ras activation in T cells appears to determine Th2-dependent eosinophilic inflammation and Ag-induced airway hyperresponsiveness.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
On the basis of their cytokine production profiles, CD4+ helper T cells can be divided into two distinct subpopulations, i.e., Th1 and Th2 cells (1). Th1 cells produce IFN-{gamma}, and Th2 cells produce IL-4, IL-5, and IL-13. The development of Th1 and Th2 cells is a central issue in understanding Th cell-dependent immune responses in infectious, allergic, and autoimmune diseases (2, 3, 4). Th1 cells play a central role in cellular immunity, whereas Th2 cells are crucial for humoral immunity and are involved in allergic and helminthic diseases.

The direction of differentiation toward Th1 and Th2 cells is dependent on the exogenous cytokines present during primary antigenic stimulation of naive T cells (4, 5, 6). IL-12-induced STAT4 activation promotes Th1 cell differentiation, whereas IL-4R-mediated signaling, including STAT6 activation, is required for Th2 cell differentiation. Ag recognition by TCR is also indispensable for both Th1 and Th2 cell differentiation (4). Flavell and colleagues (7, 8, 9) showed that Th1 cell differentiation and Th1 cytokine production are dependent on c-Jun N-terminal kinase and the p38 mitogen-activated protein kinase (MAPK)3 cascade, respectively. We have reported that there is a preferential requirement for the TCR-induced activation of p56lck, calcineurin, and the Ras/MAPK cascade in the differentiation of Th2 cells (10, 11, 12). We analyzed the efficiency of Th1/Th2 cell differentiation in naive T cells from H-ras-dominant-negative Ras (dnRas) transgenic (Tg) mice, in which enzymatically inactive Ras molecules were overexpressed, and found that TCR-induced MAPK cascade activation was strongly compromised. Severely impaired Th2 cell differentiation and increased Th1 cell differentiation were observed, whereas other functions, such as anti-TCR-induced proliferative responses and IL-2 production, were within normal ranges (12). In addition, in vivo Ag-induced Th2 responses, such as Ag-specific IgG1 and IgE production, were impaired, whereas Th1-dependent IgG2a immune responses were enhanced. However, it has not been elucidated whether IL-5 production and Th2-dependent eosinophilic inflammation are also dependent on the activation of the Ras/MAPK cascade in T cells.

Airway inflammation is a central issue in the pathogenesis of asthma. The airway of asthma patients demonstrates chronic inflammation characterized by leukocyte infiltration in the peribronchiolar and perivascular regions of the lung, hypersecretion of mucus, obstruction of airways, epithelial damage, and basement membrane thickening (13). Recent clinical and experimental investigations revealed crucial roles for CD4+ Th2 cells and eosinophils in allergic airway inflammation and hyperresponsiveness (14, 15, 16). Th2 cytokines, including IL-4, IL-5, and IL-13, appear to play a crucial role in the development of allergic airway inflammation (17, 18). IL-4 has been suggested to be important for the generation of allergen-specific Th2 cells during sensitization (19), whereas IL-13 is thought to be more important in the induction of airway hyperresponsiveness (20, 21, 22). In contrast, IL-5 appears to be critical for the induction of eosinophilic inflammation in bronchial tissues (23, 24, 25). However, the differential roles for these Th2 cytokines in the development of allergic asthma remain ambiguous.

Here, we used dnRas Tg mice to assess the role of Ras activation in OVA-induced allergic airway inflammation in a mouse asthma model. Our results suggest that the levels of Ras activation in T cells determine the development of Th2-dependent eosinophilic inflammation and Ag-induced airway hyperresponsiveness.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

A Tg mouse with T cell-specific dnRas expression driven by the lck proximal promoter was characterized previously (12, 26). In this report, 6- to 8-wk-old heterozygous (Tg+/-) dnRas Tg mice with a (C56BL/6 (B6) x BALB/c)F1 background were used. All mice used in this study were maintained under specific pathogen-free conditions. Animal care was in accordance with the guidelines of Chiba University (Chiba, Japan).

Immunization and airway challenge with OVA

dnRas Tg mice 6–8 wk old were immunized i.p. with 100 µg of OVA (chicken egg albumin; Sigma-Aldrich, St. Louis, MO) in 1 mg of aluminum hydroxide gel (alum) on days 0 and 7. On days 14, 15, and 16, the sensitized mice inhaled aerosolized OVA for 30 min in a chamber (31 x 23 x13 cm) connected to a nebulizer that generates a 1% w/v OVA aerosol mist. Control mice inhaled 0.9% saline.

Cytokine production in vitro

Two weeks after the last OVA or Nippostrongylus brasiliensis injection, the spleens were removed. Whole spleen cell populations were cultured for 3 days with 6.25–50 µg/ml DNP-N. brasiliensis Ag or 3–100 µg/ml OVA (27). The concentrations of cytokines (IL-4, IL-5, IL-13, and IFN-{gamma}) in the culture supernatant were quantified by standard ELISA as described previously (28).

Collection and analysis of bronchoalveolar lavage (BAL) fluid

Two days after the last OVA inhalation, BAL was performed as described (29). Total BAL fluid was collected, and the cells in 100-µl aliquots were counted. One hundred thousand viable BAL cells were cytocentrifuged onto slides by a Cytospin 3 (Shandon, Pittsburgh, PA), and stained with May-Grünwald-Giemsa solution (Merck, Rahway, NJ) as described (24). Two hundred leukocytes were counted on each slide. Cell types were identified based on morphological criteria. The percentages and absolute numbers of each cell type were calculated.

Lung histology

Two days after the last OVA inhalation, the lungs were fixed in 4% paraformaldehyde-PBS, dehydrated in 50–100% ethanol-propanol-xylene, and embedded in paraffin. Then the samples were sectioned and stained with H&E or Luna (30) and examined for pathological changes under a light microscope at x80 and x160.

Measurement of airway responsiveness

Airway responsiveness was assessed by methacholine-induced airflow obstruction of conscious mice placed in a whole body plethysmograph (model PLY3211; Buxco Electronics, Troy, NY) as described (29). The respiratory parameters were obtained by exposing mice to 0.9% saline aerosol, followed by incremental doses (3–50 mg/ml) of aerosolized methacholine. Airflow obstruction was monitored and analyzed by system XA software (model SFT1610; Buxco Electronics). Results are expressed as the percentage of baseline enhanced pause values after 0.9% saline exposure.

Helminthic infection and the measurement of Th2 responses.

dnRas Tg mice were injected s.c. with 750 third-stage N. brasiliensis larvae on days 0 and 21 or inoculated orally with 300 third-stage Heligmosomoides polygyrus larvae (27, 31). To determine the number of eosinophils in the blood, mice were bled 14 days after primary and 7 days after secondary N. brasiliensis infection and 21 days after H. polygyrus infection. The number of eosinophils was counted under a microscope after staining with Hinkelmann’s solution. The number of eosinophils before primary or secondary infection was <50/ml.

Statistical analysis.

Student’s t test was used to evaluate the significance of the differences.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
OVA-induced IL-5 production is decreased in dnRas Tg mice

The goal of this study was to evaluate the roles for Ras activation in T cells in allergic airway inflammation and airway hyperresponsiveness. We initiated the analysis by assessing Ag-induced Th2 cytokine production in dnRas Tg mice, where Ras activation is inhibited specifically in T cells. Eight-week-old dnRas Tg mice with a (B6 x BALB/c)F1 background were immunized with OVA in alum. Two weeks later, spleen cells were individually prepared, and in vitro Ag-induced cytokine production was measured (Fig. 1Go). As can be seen, OVA Ag dosage-dependent increases in the production of Th2 cytokines (IL-4, IL-5, and IL-13) were observed in littermate (LM) mice and, as expected, significantly reduced responses in the dnRas Tg cultures were detected. In contrast, a slight enhancement of IFN-{gamma} production was detected. The production of IL-2 appeared to be slightly decreased. These results are consistent with the previous finding that Th2 cell differentiation is impaired in dnRas Tg mice (12), as is Ag-specific IgE production. Here, Ag-induced IL-5 and IL-13 production are revealed to be attenuated in dnRas Tg mice.



View larger version (29K):
[in this window]
[in a new window]
 
FIGURE 1. Impaired OVA-induced Th2 cytokine production in dnRas Tg mice. Eight week-old dnRas Tg mice were immunized i.p. with 100 µg of OVA in 1 mg of alum on days 0 and 7. Two weeks later, whole spleen cells were individually prepared and cultured with 3–100 µg/ml OVA for 3 days. The production of cytokines in the culture supernatant was assessed by ELISA. The values in individual mouse cultures are means ± SD. Four mice were used in each group. Statistical significance was assessed by Student’s t test (see Materials and Methods). Values of p (LM vs dnRas) are: IL-4, <0.0001, 0.19, 0.05, 0.04 from left to right; IL-5, <0.0001, <0.0001, 0.01, 0.02 from left to right; IL-13, 0.18, 0.10, 0.05, 0.02 from left to right; IFN-{gamma}, 0.55 0.04, 0.38, 0.08 from left to right; IL-2, 0.78, 0.20, 0.13, 0.26 from left to right.

 
Decreased OVA-induced eosinophilic infiltration in the airway of dnRas Tg mice

Two weeks after OVA immunization, dnRas Tg mice were exposed to inhaled OVA for 3 consecutive days, and a further 2 days later BAL fluid was examined for eosinophilic infiltration. As can be seen in Fig. 2GoA, the majority of infiltrated cells were eosinophils in LM mice. The percentages and absolute numbers of eosinophils, macrophages, and neutrophils were calculated as described in Materials and Methods. Fig. 2GoB shows significantly decreased frequencies of eosinophils and increased frequencies of macrophages. As shown in Fig. 2GoC, a substantial reduction in the absolute number of eosinophils was revealed. The number of leukocytes in the BAL fluid was significantly reduced in dnRas Tg mice (see total). According to morphological criteria, the number of lymphocytes was negligible in the cells designated as "others." They appeared to be blast cells (data not shown). We also measured cytokines (IL-2, IL-4, IFN-{gamma}, and IL-5) in the BAL fluid. Under our conditions, only IL-5 was detectable by ELISA, and slightly decreased concentrations were consistently detected in the dnRas Tg groups (Fig. 2GoD).



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 2. Reduced eosinophilic infiltration in the airways of OVA-primed dnRas Tg mice. OVA-sensitized dnRas Tg mice were exposed to OVA mist. Four normal and four dnRas Tg mice were used in each group. Two days after the last exposure, the mice were sacrificed, and BAL fluid was collected. Eosinophils in the BAL fluid were detected on cytospins after staining with May-Grünwald-Giemsa solution and quantified after counting 200 cells. A, Representative staining patterns. x200. The percentages (B) and absolute numbers (C) of eosinophils (Eosino.), macrophages (Macro.), and neutrophils (Neutro.) are shown with SD. The results were obtained using the values of the percentages of each cell type, the total cell number per milliliter, and the recovered volume of BAL fluid. Values of p in B were determined by Student’s t test, The values are as follows; 0.008 (Eosino.), 0.023 (Macro.), 0.5< (Neutro.), and 0.01 (others). Values of p in C are: 0.008 (Eosino.); 0.37 (Macro.); 0.25 (Neutro.); 0.38 (others); 0.009 (total). (D) IL-5 production in the BAL fluid assessed by ELISA. The p value in D was determined by Student’s t test and was 0.04.

 
Concurrently, changes in the lung were evaluated histologically by H&E staining (Fig. 3Go). Leukocyte infiltration in peribronchiolar regions was significantly milder in dnRas Tg mice than in control mice (Fig. 3GoA, compare a and b). Bronchiolar mucus hyperproduction and airway obstruction were often seen in littermate controls (Fig. 3GoAa). A summary of infiltrated leukocyte numbers is shown in Fig. 3GoB, where a significant reduction was noted. Simultaneously, the sections were stained with Luna, and perivascular and peribronchiolar regions were assessed for eosinophilic infiltration (Fig. 3GoC). Although some perivascular and peribronchiolar regions showed the presence of significant numbers of leukocytes in dnRas Tg lung (Fig. 3GoC, c and d), the number of eosinophils was clearly fewer in dnRas Tg mice than in LM controls. Taken together, these results suggest that OVA-induced IL-5 and eosinophilic inflammation in the lung is dependent on the levels of Ras activation in T cells.



View larger version (87K):
[in this window]
[in a new window]
 
FIGURE 3. Histological analysis of lung sections from dnRas Tg mice subjected to OVA immunization and inhalation. The dnRas Tg mice were immunized with OVA and then exposed to an OVA mist as in Fig. 2Go. The lungs were fixed and stained with H&E (A) or Luna (C). A, x80; C, x160. Sections shown are representative of 10 lung sections per mouse from 5 mice in each group. B, Results of semiquantitative analysis of peribronchiolar leukocyte infiltrates. C, Perivascular (a and c) and peribronchiolar (b and d) eosinophilic infiltrates were assessed. Infiltrate eosinophils are visualized as orange cells and noted in LM control groups (a and b). Percentages of eosinophils in the infiltrated leukocytes are 25.8 + 1.8% in LM and 2.3 + 0.1% in dnRas Tg mice. The p value was determined by Student’s t test and was 0.0002.

 
Reduced airway hyperresponsiveness to methacholine in dnRas Tg mice

To assess the levels of airway hyperresponsiveness in OVA-sensitized mice, dnRas Tg mice were immunized and exposed to inhaled OVA. Then airway hyperresponsiveness was assessed by measuring methacholine-induced airflow obstruction in a whole body plethysmograph. As shown in Fig. 4GoA, airway hyperresponsiveness was diminished in the dnRas Tg mice. The levels of airway hyperresponsiveness in nonsensitized dnRas Tg mice were similarly assessed and did not reveal a significant difference between normal and dnRas Tg mice (Fig. 4GoB), suggesting that the baseline level of airway hyperresponsiveness was not altered in dnRas Tg mice. Thus, the Ras activation level was found to control the development of airway hyperresponsiveness in a mouse OVA-induced asthma model.



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 4. Assessment of airway hyperresponsiveness of dnRas Tg mice. A, dnRas Tg mice sensitized with OVA were exposed to OVA mist on days 14, 15, and 16. Two days after the last OVA inhalation, airway hyperresponsiveness in response to increasing doses of inhaled methacholine was measured in a whole body plethysmograph. Values are means of percentages above baseline ± SD for four mice. Four independent experiments were done with similar results. B, dnRas Tg and normal LM mice without OVA sensitization were subjected to the assessment of airway hyperresponsiveness.

 
Eosinophilia induced by nematode infection is less severe in dnRas Tg mice

Finally, we assessed the role of Ras activation in eosinophilia induced by nematode infection. Eight-week-old dnRas Tg mice were infected with N. brasiliensis or H. polygyrus, both of which are known to induce eosinophilic inflammation in experimental mice (32, 33). The number of eosinophils in the peripheral blood of uninfected normal mice was lower than 50/mm3 (data not shown). As shown in Fig. 5GoA, the number of eosinophils increased greatly after primary or secondary infection with N. brasiliensis in wild-type LM (B6 x BALB/c)F1 mice. The levels of eosinophilia were significantly lower in the dnRas Tg groups. In H. polygyrus infection, the numbers of eosinophils in the blood of dnRas Tg mice were reduced to about one-half to one-third of those in LM controls (experiment 1 or 2). Concurrently, we prepared spleen cells from N. brasiliensis-infected animals, and N. brasiliensis Ag-induced cytokine production in vitro was assessed. As can be seen in Fig. 5GoB, the production of IL-5 and IL-13 was significantly reduced in dnRas Tg cultures. A slight increase in the production of IFN-{gamma} was observed. The decrease in the production of IL-4 in dnRas groups was not as prominent (Fig. 5GoB, lL-4 panel). The reason for this apparent disparity from the OVA challenge data (see earlier) is not know, but the N. brasiliensis Ag-specific response may have been masked by a high background level of IL-4 production (~50 pg/ml) by spleen cells from N. brasiliensis-infected mice (see Fig. 5GoB, IL-4 panel, extreme left). Only at the highest in vitro DNP-N. brasiliensis Ag dose of 50 µg/ml does the difference in IL-4 production become evident where the highest level of IL-4 detected reached ~150 pg/ml. In any event, IL-5 production and eosinophilia induced by nematode infection also appear to be dependent on the levels of activation of Ras in T cells.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 5. The levels of eosinophilia and Th2 cytokine response in dnRas Tg mice infected with nematodes. Eight-week-old dnRas Tg mice were injected s.c. with 750 third-stage N. brasiliensis (Nb) larvae on days 0 and 21 or inoculated orally with 300 third-stage Heligmosomoides polygyrus larvae. A, The numbers of eosinophils 14 days after primary and 7 days after secondary N. brasiliensis infection were determined (left). For H. polygyrus infection, two representative results (Exp. 1 and Exp. 2) are shown. Values are means ± SD for five mice in each group. Values of p were determined by Student’s t test. Values of p in A: after primary infection, 0.017; after secondary infection, 0.027. Values of p in B: Exp. 1, 0.05; Exp. 2, 0.0023. B, dnRas Tg mice were immunized with N. brasiliensis as in A. Two weeks after the last immunization, whole spleen cells (1 x 106) were prepared and cultured with the indicated concentrations of DNP-N. brasiliensis Ag. Values are means ± SD of cytokine production in the culture supernatant determined by ELISA. Three independent experiments were done with similar results. {square}, LM mice; {blacksquare}, dnRas Tg mice. Values of p were determined by Student’s t test and were as follows: IL-4, 0 µg/ml: 0.5<, 6.25 µg/ml: 0.5<, 12.5 µg/ml: 0.5<, 25 µg/ml: 0.5<, 50 µg/ml: 0.004. IL-5, 6.25 µg/ml: 0.001, 12.5 µg/ml: <0.0001, 25 µg/ml: <0.0001, 50 µg/ml: 0.05. IL-13, 6.25 µg/ml: 0.04, 12.5 µg/ml: 0.005, 25 µg/ml: <0.001, 50 µg/ml: 0.5<. IFN-{gamma}, 0 µg/ml: 0.03, 6.25 µg/ml: 0.33, 12.5 µg/ml: 0.22, 25 µg/ml: 0.003, 50 µg/ml: 0.01.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Clinical and biological manifestations of bronchial asthma are heterogeneous, reflecting a multitude of causative factors and the presence of complex pathophysiological mechanisms. Murine models of allergic lung diseases have been used to dissect the underlying complex pathogenesis in asthma (15). In this report, we used the OVA-induced allergic asthma model to demonstrate that the development of both Ag-induced eosinophilic airway inflammation and airway hyperresponsiveness depend largely on the levels of Ras activation in T cells. We reported previously that Th2 cell differentiation is impaired in dnRas Tg mice (12). In the present study, the decreased production of Th2 cytokines (IL-4, IL-5, and IL-13) in Ag-primed dnRas Tg T cells is confirmed (Fig. 1Go). Thus, it is conceivable that the block in the development of eosinophilic airway inflammation and airway hyperresponsiveness is a consequence of the reduced generation of Ag-specific Th2 cells during OVA sensitization. Undoubtedly, however, there are effects of dnRas downstream of Th2 priming.

IL-5 is critical for the development of eosinophilic inflammation (34). Airway eosinophilic inflammation and airway hyperresponsiveness have been demonstrated to be reduced by anti-IL-5 Ab treatment and IL-5 gene deletion in mice (24, 25). Furthermore, ectopic Tg expression of IL-5 in the lung epithelium results in eosinophilic invasion of airways comparable with that seen in asthmatic patients (35). Interestingly, the IL-5 Tg mice displayed airway hyperresponsiveness in the absence of Ag-induced inflammation. Thus, IL-5 appears to be most critical for the development of airway eosinophilic inflammation and also the development of airway hyperresponsiveness. In dnRas Tg mice, significantly reduced IL-5 levels were seen (Fig. 1Go). Because the production of IL-4 and IL-13 was also reduced in dnRas Tg mice, it is not so easy to estimate the contribution of the IL-5 deficit to the attenuated airway inflammation. However, it is now clear that the activation of Ras is involved in the pathogenesis of both eosinophilic inflammation and airway hyperresponsiveness.

Our previous results indicate that the efficiency of Th2 cell differentiation depends on the activation level of the Ras/extracellular signal-regulated kinase (ERK) MAPK cascade (12). Consistent with this observation, the production of Th2 cytokines (IL-4, IL-5, and IL-13) was impaired in dnRas Tg T cells (Fig. 1Go). In naive CD4 T cells, stimulation with a very large amount of IL-4 (100 U/ml) did not induce detectable levels of ERK MAPK cascade activation (our unpublished observations). In contrast, TCR stimulation induced a substantial increase in the level of ERK phosphorylation (12). These results suggest that activation of the Ras/ERK MAPK cascade in naive CD4 T cells is a consequence of TCR-mediated signaling. The downstream functional target molecules of ERK-MAPK in Th2 cell differentiation are not clarified very well at this time. One candidate is the IL-4R signaling complex (12). IL-4-induced tyrosine phosphorylation of Jak1 and STAT6, which reflects the strength of IL-4R signaling, was enhanced when naive T cells were exposed to short term treatment with PMA (an agonistic of the Ras/MAPK cascade), suggesting that activation of Ras/MAPK cascade up-regulated IL-4R function. Another candidate is NF-{kappa}B. A role for NF-{kappa}B in GATA3 expression and Th2 cell differentiation was demonstrated in an allergic airway inflammation system using mice that lack the p50 subunit of NF-{kappa}B (36). Although we observed weak activation of NF-{kappa}B signaling in purified naive CD4 T cells after stimulation with anti-TCR mAb, the activation was not inhibited by treatment with PD98059 (our unpublished observations), suggesting that this NF-{kappa}B activation is not dependent on the ERK MAPK cascade. Thus, NF-{kappa}B regulation of GATA3 expression may not be involved in the observed ERK MAPK-mediated regulation of allergic airway inflammation.

The accumulated results implicating the involvement of the activation of Th2 cells in the development of asthma support several new strategies that could attenuate Th2-induced airway inflammation in the asthmatic airway. Most of the strategies aim to block Th2 cell differentiation and the production of Th2 cytokines (37, 38). One of the potential strategies is to develop drugs that block the signal transduction pathway required for Th2 cell differentiation. Inhibition of the Ras pathway, as shown in the present study, could alter the cytokine pattern by suppressing IL-4, IL-5 and IL-13 and enhancing IFN-{gamma} production. In fact, a mitogen-activated protein/extracellular signal-related kinase kinase inhibitor, U0126, has been shown to reduce IL-13-induced cell stiffness in cultured human airway smooth muscle cells, a model of airway narrowing observed in patients with asthma (39). In addition, several other independent pathways downstream of Ras have been reported and appear to mediate the distinct biological functions of Ras. The activation of Ras results in the phosphorylation of p70/S6 kinases (40). Rapamycin, a p70/S6 kinase inhibitor, has been reported to inhibit the proliferation of T lymphocytes from patients with chronic asthma, and rapamycin has been suggested to be useful in clinical trials for asthmatic patients given their modes of action in T cells (41). Thus, specific blockade of the Ras-Raf/ERK MAPK pathway may have therapeutic value in asthma.

In summary, in a mouse allergic asthma model, the activation of Ras in T cells controls the development of Th2-dependent eosinophilic airway inflammation and airway hyperresponsiveness. Thus, a search for specific inhibitors focusing on Ras-mediated signaling pathways would be helpful for establishing a new approach to the treatment of inflammatory diseases such as bronchial asthma.


    Acknowledgments
 
We thank Dr. P. A. Koni (Medical College of Georgia and RIKEN Research Center for Allergy and Immunology) and H. Nakajima (Chiba University, Japan) for helpful comments and constructive criticisms in the preparation of the manuscript, Drs. K. Harigaya and M. Higashi for the histological analyses, and Kaoru Sugaya for excellent technical assistance.


    Footnotes
 
1 This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (Japan) (Grants-in-Aid for Scientific Research, Priority Areas Research 13218016 and 12051203; Scientific Research A13307011, B14370107, and C12670293; and Special Coordination Funds for Promoting Science and Technology); the Ministry of Health, Labor and Welfare (Japan); the Program for Promotion of Fundamental Studies in Health Science of the Organization for Pharmaceutical Safety and Research (Japan); and Human Frontier Science Program Research Grant RG00168/2000-M206. Back

2 Address correspondence and reprint requests to Dr. Toshinori Nakayama, Department of Medical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail address: nakayama{at}med.m.chiba-u.ac.jp Back

3 Abbreviations used in this paper: MAPK, mitogen-activated protein kinase; BAL, bronchoalveolar lavage; dnRas, H-ras-dominant negative Ras; LM, littermate; Tg, transgenic; ERK, extracellular signal-regulated kinase. Back

Received for publication February 19, 2002. Accepted for publication June 7, 2002.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.[Abstract]
  2. Romagnani, S.. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.[Medline]
  3. Reiner, S. L., R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.[Medline]
  4. Abbas, A. K., K. M. Murphy, A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.[Medline]
  5. Constant, S. L., K. Bottomly. 1997. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.[Medline]
  6. O’Garra, A.. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.[Medline]
  7. Dong, C., D. D. Yang, M. Wysk, A. J. Whitmarsh, R. J. Davis, R. A. Flavell. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282:2092.[Abstract/Free Full Text]
  8. Rincon, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. S. Su, L. A. Penix, R. J. Davis, R. A. Flavell. 1998. Interferon-g expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:2817.[Medline]
  9. Yang, D. D., D. Conze, A. J. Whitmarsh, T. Barrett, R. J. Davis, M. Rincon, R. A. Flavell. 1998. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9:575.[Medline]
  10. Yamashita, M., K. Hashimoto, M. Kimura, M. Kubo, T. Tada, T. Nakayama. 1998. Requirement for p56lck tyrosine kinase activation in Th subset differentiation. Int. Immunol. 10:577.[Abstract/Free Full Text]
  11. Yamashita, M., M. Katsumata, M. Iwashima, M. Kimura, C. Shimizu, T. Kamata, T. Shin, N. Seki, S. Suzuki, M. Taniguchi, T. Nakayama. 2000. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex. J. Exp. Med. 191:1869.[Abstract/Free Full Text]
  12. Yamashita, M., M. Kimura, M. Kubo, C. Shimizu, T. Tada, R. M. Perlmutter, T. Nakayama. 1999. T cell antigen receptor-mediated activation of the Ras/mitogen- activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. USA 96:1024.[Abstract/Free Full Text]
  13. Jr McFadden, E. R., I. A. Gilbert. 1992. Asthma. N. Engl. J. Med. 327:1928.[Abstract]
  14. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.[Abstract]
  15. Lloyd, C. M., J. A. Gonzalo, A. J. Coyle, J. C. Gutierrez-Ramos. 2001. Mouse models of allergic airway disease. Adv. Immunol. 77:263.[Medline]
  16. Wills-Karp, M.. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255.[Medline]
  17. Drazen, J. M., J. P. Arm, K. F. Austen. 1996. Sorting out the cytokines of asthma. J. Exp. Med. 183:1.[Free Full Text]
  18. Venkayya, R., M. Lam, M. Willkom, G. Grunig, D. B. Corry, D. J. Erle. 2002. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am. J. Respir. Cell Mol. Biol. 26:202.[Abstract/Free Full Text]
  19. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109.[Abstract/Free Full Text]
  20. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261.[Abstract/Free Full Text]
  21. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258.[Abstract/Free Full Text]
  22. Walter, D. M., J. J. McIntire, G. Berry, A. N. McKenzie, D. D. Donaldson, R. H. DeKruyff, D. T. Umetsu. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167:4668.[Abstract/Free Full Text]
  23. Nakajima, H., I. Iwamoto, S. Tomoe, R. Matsumura, H. Tomioka, K. Takatsu, S. Yoshida. 1992. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374.[Medline]
  24. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.[Abstract/Free Full Text]
  25. Hamelmann, E., G. Cieslewicz, J. Schwarze, T. Ishizuka, A. Joetham, C. Heusser, E. W. Gelfand. 1999. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 160:934.[Abstract/Free Full Text]
  26. Swan, K. A., J. Alberola-Ila, J. A. Gross, M. W. Appleby, K. A. Forbush, J. F. Thomas, R. M. Perlmutter. 1995. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J. 14:276.[Medline]
  27. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et al 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Va14 natural killer T cells. J. Exp. Med. 190:783.[Abstract/Free Full Text]
  28. Kimura, M., Y. Koseki, M. Yamashita, N. Watanabe, C. Shimizu, T. Katsumoto, T. Kitamura, M. Taniguchi, H. Koseki, T. Nakayama. 2001. Regulation of Th2 cell differentiation by mel-18, a mammalian polycomb group gene. Immunity 15:275.[Medline]
  29. Hansen, G., G. Berry, R. H. DeKruyff, D. T. Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:175.[Medline]
  30. Nichols, D. H., S. Lovas, T. E. Adrian, C. A. Miller, R. F. Murphy. 1998. Peptides bind to eosinophils in the rat stomach. Anat. Rec. 250:172.[Medline]
  31. Jr Urban, J. F., I. M. Katona, F. D. Finkelman. 1991. Heligmosomoides polygyrus: CD4+ but not CD8+ T cells regulate the IgE response and protective immunity in mice. Exp. Parasitol. 73:500.[Medline]
  32. Coffman, R. L., B. W. Seymour, S. Hudak, J. Jackson, D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308.[Abstract/Free Full Text]
  33. Jr Urban, J. F., K. B. Madden, A. Svetic, A. Cheever, P. P. Trotta, W. C. Gause, I. M. Katona, F. D. Finkelman. 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol. Rev. 127:205.[Medline]
  34. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43.[Abstract/Free Full Text]
  35. Lee, J. J., M. P. McGarry, S. C. Farmer, K. L. Denzler, K. A. Larson, P. E. Carrigan, I. E. Brenneise, M. A. Horton, A. Haczku, E. W. Gelfand, et al 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143.[Abstract/Free Full Text]
  36. Das, J., C. H. Chen, L. Yang, L. Cohn, P. Ray, A. Ray. 2001. A critical role for NF-{kappa}B in GATA3 expression and Th2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45.[Medline]
  37. Ray, A., L. Cohn. 1999. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin. Invest. 104:985.[Medline]
  38. Barnes, P. J.. 2001. Cytokine-directed therapies for asthma. J. Allergy Clin. Immunol. 108:S72.[Medline]
  39. Laporte, J. C., P. E. Moore, S. Baraldo, M. H. Jouvin, T. L. Church, I. N. Schwartzman, Jr R. A. Panettieri, J. P. Kinet, S. A. Shore. 2001. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 164:141.[Abstract/Free Full Text]
  40. Kinoshita, T., M. Shirouzu, A. Kamiya, K. Hashimoto, S. Yokoyama, A. Miyajima. 1997. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21ras in IL-3-dependent hematopoietic cells. Oncogene 15:619.[Medline]
  41. Haczku, A., A. Alexander, P. Brown, B. Assoufi, B. Li, A. B. Kay, C. Corrigan. 1994. The effect of dexamethasone, cyclosporine, and rapamycin on T- lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J. Allergy Clin. Immunol. 93:510.[Medline]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. A. Zeki, L. Franzi, J. Last, and N. J. Kenyon
Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and Beyond
Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 731 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Shinnakasu, M. Yamashita, M. Kuwahara, H. Hosokawa, A. Hasegawa, S. Motohashi, and T. Nakayama
Gfi1-mediated Stabilization of GATA3 Protein Is Required for Th2 Cell Differentiation
J. Biol. Chem., October 17, 2008; 283(42): 28216 - 28225.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. G. Tirumurugaan, J. A. Jude, B. N. Kang, R. A. Panettieri, T. F. Walseth, and M. S. Kannan
TNF-{alpha} induced CD38 expression in human airway smooth muscle cells: role of MAP kinases and transcription factors NF-{kappa}B and AP-1
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1385 - L1395.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Lund, M. Loytomaki, T. Naumanen, C. Dixon, Z. Chen, H. Ahlfors, S. Tuomela, J. Tahvanainen, J. Scheinin, T. Henttinen, et al.
Genome-Wide Identification of Novel Genes Involved in Early Th1 and Th2 Cell Differentiation
J. Immunol., March 15, 2007; 178(6): 3648 - 3660.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Hosokawa, M. Y. Kimura, R. Shinnakasu, A. Suzuki, T. Miki, H. Koseki, M. van Lohuizen, M. Yamashita, and T. Nakayama
Regulation of Th2 Cell Development by Polycomb Group Gene bmi-1 through the Stabilization of GATA3
J. Immunol., December 1, 2006; 177(11): 7656 - 7664.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hasegawa, T. Miki, H. Hosokawa, M. B. Hossain, C. Shimizu, K. Hashimoto, M. Y. Kimura, M. Yamashita, and T. Nakayama
Impaired GATA3-Dependent Chromatin Remodeling and Th2 Cell Differentiation Leading to Attenuated Allergic Airway Inflammation in Aging Mice
J. Immunol., February 15, 2006; 176(4): 2546 - 2554.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. I. Nigo, M. Yamashita, K. Hirahara, R. Shinnakasu, M. Inami, M. Kimura, A. Hasegawa, Y. Kohno, and T. Nakayama
Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function
PNAS, February 14, 2006; 103(7): 2286 - 2291.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Mizue, S. Ghani, L. Leng, C. McDonald, P. Kong, J. Baugh, S. J. Lane, J. Craft, J. Nishihira, S. C. Donnelly, et al.
Role for macrophage migration inhibitory factor in asthma
PNAS, October 4, 2005; 102(40): 14410 - 14415.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yamashita, R. Shinnakasu, H. Asou, M. Kimura, A. Hasegawa, K. Hashimoto, N. Hatano, M. Ogata, and T. Nakayama
Ras-ERK MAPK Cascade Regulates GATA3 Stability and Th2 Differentiation through Ubiquitin-Proteasome Pathway
J. Biol. Chem., August 19, 2005; 280(33): 29409 - 29419.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Murata, M. Inami, A. Hasegawa, S. Kubo, M. Kimura, M. Yamashita, H. Hosokawa, T. Nagao, K. Suzuki, K. Hashimoto, et al.
CD69-null mice protected from arthritis induced with anti-type II collagen antibodies
Int. Immunol., August 1, 2003; 15(8): 987 - 992.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, Y.
Right arrow Articles by Nakayama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, Y.
Right arrow Articles by Nakayama, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Eosinophilic Disorders


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS